Güllü Amuran G. (Yürütücü), Akkiprik M., Arğa K. Y., Erzik C., Şahin B.
TÜBİTAK Uluslararası Çoklu İşbirliği Projesi , 2023 - 2026
Background and rationale: Urothelial carcinoma (UC) is the 9th most common cancer
worldwide. There are not reliable biomarkers to predict prognosis, therapy response or
metastasis. Although liquid biopsy has emerged as a reliable tool for tumour surveillance,
nothing has been done with the circulating components of the tumour microenvironment. In
this context, UCIPredict will develop an innovative and reliable urine and blood-based
biomarker test for response prediction to immunotherapy (IT) and tumour recurrence, using
non-invasive techniques measuring circulating biomarkers from tumour and tumour
microenvironment.